Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-05

Clinical Trial Update: Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis [Phase 4]

View source ↗

Summary

Phase 4 study of bimatoprost ophthalmic solution for increasing eyelash prominence in African Americans with eyelash hypotrichosis completed; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost ophthalmic solution (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Hypotrichosis | Phase 4 | Status: COMPLETED | Results posted: 2012-01-05